What was tested
Wei Ying Peh, Dalia Abdullah and colleagues at the Universiti Kebangsaan Malaysia in Kuala Lumpur built a three-part tissue-engineered pulp substitute and asked whether adding BMP-7 would make its cells more pro-angiogenic (DOI 10.3390/ijms27198599, International Journal of Molecular Sciences, 27(19):8599). The three parts are a scaffold of decellularized human dental pulp (DHDP), made by stripping cells and nuclei from pulp of sound non-cavitated teeth extracted for orthodontic reasons in donors aged 11 to 30; Wharton’s jelly mesenchymal stem cells (WJMSCs) isolated from human umbilical cord, characterized at passage 4 and seeded into the scaffolds at passage 5, chosen because cord tissue is a non-invasive, bankable, low-immunogenicity cell source that does not depend on the patient having a donor tooth; and BMP-7 at 50 ng/mL, a growth factor the same group previously reported to drive dentinogenic differentiation of these cells in the same scaffold (DOI 10.3390/ijms262311760, their 2025 paper). The angiogenic readout was VEGFA mRNA by qRT-PCR and VEGF-A protein by immunohistochemistry, alongside scaffold physical characterization (pore size, swelling, degradation) and MTT and resazurin viability assays, over 21 days; n = 6 per group for the viability, degradation and gene-expression assays, n = 4 for pore size.
What they found
The decellularization protocol removed nuclei while leaving the pulp extracellular matrix architecture intact, judged complete by qualitative staining (hematoxylin and eosin, DAPI, electron microscopy) with no residual-DNA quantification, and the scaffold was non-cytotoxic to WJMSCs. DHDP pores were significantly larger than untreated pulp pores (12.393 vs 5.956 square micrometers, p = 0.039, n = 4), and the scaffold lost 40.19 percent of its mass by day 21 with 77.22 percent swelling. Adding BMP-7 raised WJMSC viability significantly at days 7, 14 and 21 compared with cells in DHDP alone (p < 0.01), and raised VEGFA expression at both mRNA (p = 0.002) and protein level. The authors frame this as a candidate pre-engineered pulp construct for implantation into disinfected root canals, aimed particularly at mature permanent teeth, where cell-homing regenerative procedures are less predictable.
What it does not show
No blood vessels were grown. The angiogenic endpoint is VEGF-A expression in cells sitting in a scaffold; there is no endothelial tube-formation assay, no perfusion, no ex vivo tooth model, no animal and no human in this paper, and the authors themselves state that in vivo studies and early-phase clinical trials are the required next step. The cells are not dental: WJMSCs behave differently from pulp-derived stem cells, and donor age across 11 to 30 was not controlled or stratified, so inter-donor variability is unquantified. One BMP-7 concentration was tested, and n = 6 per group with a single 21-day time course is an early characterization, not a dose-response or a demonstration that the construct survives, vascularizes or innervates after implantation. VEGF-A signal is a precondition for angiogenesis, not evidence of it.
Where it sits in the field
For the pulp and dentin repair program, this belongs to the cell-based wing rather than the cell-homing procedures the program’s human evidence rests on. The best human histology so far, including a 2026 single-premolar study on this site, shows that current regenerative endodontic procedures produce repair-adjacent tissue rather than a rebuilt pulp-dentin complex, and the authors of today’s paper use exactly that gap as their rationale for a pre-engineered construct. Their triad is coherent as engineering: a bankable allogeneic cell source, a pulp-specific human matrix, and a growth factor their own prior work ties to dentinogenic differentiation, now extended to a pro-angiogenic readout. It qualifies rather than strengthens the program’s tier 3: an in vitro signaling result on one construct does not move human evidence. The current field assessment stands at /field/.
Where we differ from the coverage
We found no press or popular coverage of this paper to differ from. Against the paper’s own translational framing, we hold back one inference: the closing sections propose implantation of this construct into a disinfected root canal, but nothing in the study tests survival, integration or vascular anastomosis after implantation, and the honest summary of the result is that BMP-7 at one concentration increased VEGF-A expression of cord-derived stem cells in a decellularized pulp scaffold over 21 days in a dish.
Provenance: grounded in the full text of record (PubMed Central PMC13665202), retrieved 18 October 2026; every number above is taken from the article’s abstract, results text and figure captions. Method and sourcing standard at /method/.